Breaking News Instant updates and real-time market news.

LGF.A

Lionsgate

$28.15

-0.11 (-0.39%)

, LGF.B

Lionsgate

$27.02

-0.14 (-0.52%)

13:02
02/15/18
02/15
13:02
02/15/18
13:02

Lionsgate price target lowered to $34 from $40 at Barrington

Barrington analyst James Goss said that with Lionsgate repositioning its film slate under new leadership, and increasing its investment in programming for Starz, the company sees more muted growth in 2019, but then sees a significant ramp in 2020. While Goss sees near-term upside being muted, he believes the Starz service will be a more attractive offering in the "shifting media landscape," which should provide further opportunities for long-term growth, and he reaffirms his Outperform rating despite moving the price target for Lionsgate shares to $34 from $40.

LGF.A

Lionsgate

$28.15

-0.11 (-0.39%)

LGF.B

Lionsgate

$27.02

-0.14 (-0.52%)

  • 20

    Mar

LGF.A Lionsgate
$28.15

-0.11 (-0.39%)

01/30/18
01/30/18
DOWNGRADE
Target $35

Equal Weight
Lionsgate downgraded to Equal Weight on lower Starz view at Morgan Stanley
As previously reported, Morgan Stanley analyst Benjamin Swinburne downgraded Lionsgate to Equal Weight from Overweight after lowering his estimates on Starz. As a result of lower Starz estimates, Swinburne is now expecting fairly muted consolidated EBITDA growth for FY19 and views FY20 as being more dependent on film success, which inherently has lower visibility. While he agrees that some degree of acquisition premium should be factored into Lionsgate shares, Swinburne contends that for a hypothetical traditional media buyer there likely would be minimal accretion given the stock's current premium multiple, he added. He keeps a $35 price target on Lionsgate shares.
02/09/18
RHCO
02/09/18
DOWNGRADE
RHCO
Hold
Lionsgate downgraded to Hold from Buy at SunTrust
02/09/18
KEYB
02/09/18
DOWNGRADE
KEYB
Sector Weight
Lionsgate downgraded to Sector Weight from Overweight at KeyBanc
02/09/18
MSCO
02/09/18
NO CHANGE
Target $35
MSCO
Equal Weight
Lionsgate progress with Altice could help FY19, says Morgan Stanley
Lionsgate analyst Benjamin Swinburne noted that Lionsgate's (LGF.A) Q3 results were broadly in-line with expectations, although Starz subscriber metrics were lower than expected and the company lowered its three year growth expectation to mid to high single digits. However, Lionsgate mentioned on its earnings call that it continues to talk to Altice (ATUS) and hopes an agreement can be reached "imminently," which could be a benefit to FY19, noted Swinburne, who keeps an Equal Weight rating and $35 price target on Lionsgate shares.
LGF.B Lionsgate
$27.02

-0.14 (-0.52%)

01/19/18
RHCO
01/19/18
NO CHANGE
Target $36
RHCO
Buy
Lionsgate price target raised to $36 from $31 at SunTrust
SunTrust analyst Matthew Thornton raised his price target on Lionsgate to $36 and kept his Buy rating amid the pick-up in takeover speculation this week. Thornton says the reports of several potential suitors looking at the company are not surprising amid Lionsgate's "participation in sector consolidation", modeling an average/median acquisition price of up to $41 per share.
02/09/18
RHCO
02/09/18
DOWNGRADE
Target $31
RHCO
Hold
Lionsgate downgraded to Hold from Buy at SunTrust
SunTrust analyst Matthew Thornton downgraded Lionsgate (LGF.B) to Hold from Buy and lowered his price target to $31 from $36 after the company lowered its 3-year OIBDA growth outlook to 7.8% from about 13% amid accelerated investment in Starz and international divisions. Thornton notes that while the added spending is justifiable, the multiple needs to reflect the updated model as confidence in more back-end loaded guidance has been shaken. Among his areas of concern, Thornton also lists "accelerating mix shift to originals from licensed content", impact of Netflix (NFLX) on box office and competition for projects, and impact on Starz from bundling deals such as T-Mobile (TMUS) with Netflix and AT&T (T) with HBO.
02/12/18
RBCM
02/12/18
NO CHANGE
Target $35
RBCM
Outperform
Lionsgate price target lowered to $35 from $40 at RBC Capital
RBC Capital analyst Steven Cahall lowered his price target on Lionsgate to $35 after the company reduced its outlook on annual growth due to shifts at Motion Picture unit and Starz investments. Cahall keeps his Outperform rating, adding that despite the tempered earnings growth, the longer-term investment story on the company remains compelling as it is "least exposed to scary media ecosystem concerns, and the best takeout candidate".

TODAY'S FREE FLY STORIES

LDOS

Leidos

$65.75

0.54 (0.83%)

05:47
02/23/18
02/23
05:47
02/23/18
05:47
Recommendations
Leidos analyst commentary  »

Jefferies views Leidos as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENTL

Entellus Medical

05:45
02/23/18
02/23
05:45
02/23/18
05:45
Conference/Events
Entellus Medical to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

FSLR

First Solar

$66.28

-0.42 (-0.63%)

05:44
02/23/18
02/23
05:44
02/23/18
05:44
Recommendations
First Solar analyst commentary  »

First Solar outlook has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Mar

HPP

Hudson Pacific

$30.66

0.42 (1.39%)

05:41
02/23/18
02/23
05:41
02/23/18
05:41
Upgrade
Hudson Pacific rating change  »

Hudson Pacific upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OJSCY

Rosneft

05:40
02/23/18
02/23
05:40
02/23/18
05:40
Downgrade
Rosneft rating change  »

Rosneft downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MIC

Macquarie Infrastructure

$37.41

-26.21 (-41.20%)

05:39
02/23/18
02/23
05:39
02/23/18
05:39
Downgrade
Macquarie Infrastructure rating change  »

Macquarie Infrastructure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACIA

Acacia Communications

$41.84

-1.6 (-3.68%)

05:39
02/23/18
02/23
05:39
02/23/18
05:39
Downgrade
Acacia Communications rating change  »

Acacia Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 13

    Mar

  • 29

    Mar

XPO

XPO Logistics

$93.56

-0.43 (-0.46%)

05:37
02/23/18
02/23
05:37
02/23/18
05:37
Recommendations
XPO Logistics analyst commentary  »

XPO free cash flow growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNY

Sanofi

$39.85

0.34 (0.86%)

, BIVV

Bioverativ

$104.30

0.39 (0.38%)

05:35
02/23/18
02/23
05:35
02/23/18
05:35
Hot Stocks
Sanofi announces expiration of HSR waiting period for acquisition of Bioverativ »

Sanofi (SNY) announced…

SNY

Sanofi

$39.85

0.34 (0.86%)

BIVV

Bioverativ

$104.30

0.39 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

  • 25

    Mar

  • 25

    Apr

  • 02

    May

KNX

Knight-Swift

$47.83

-0.47 (-0.97%)

05:34
02/23/18
02/23
05:34
02/23/18
05:34
Recommendations
Knight-Swift analyst commentary  »

Knight-Swift consensus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBGL

Sibanye Gold

$4.05

-0.38 (-8.58%)

05:26
02/23/18
02/23
05:26
02/23/18
05:26
Upgrade
Sibanye Gold rating change  »

Sibanye Gold upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INGIF

Ingenico Group

05:23
02/23/18
02/23
05:23
02/23/18
05:23
Downgrade
Ingenico Group rating change  »

Ingenico Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOMO

Momo

$30.53

-1.44 (-4.50%)

05:22
02/23/18
02/23
05:22
02/23/18
05:22
Hot Stocks
Momo acquires Tantan in cash, stock transaction »

Momo announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDDY

GoDaddy

$55.43

-0.27 (-0.48%)

05:20
02/23/18
02/23
05:20
02/23/18
05:20
Recommendations
GoDaddy analyst commentary  »

GoDaddy price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 28

    Mar

SRE

Sempra Energy

$106.64

1.21 (1.15%)

05:19
02/23/18
02/23
05:19
02/23/18
05:19
Hot Stocks
Sempra Energy raises annualized dividend by 9% to $3.58 per share »

Sempra Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

MB

Mindbody

$35.55

2.2 (6.60%)

05:18
02/23/18
02/23
05:18
02/23/18
05:18
Recommendations
Mindbody analyst commentary  »

Mindbody price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 26

    Feb

  • 26

    Feb

FNGN

Financial Engines

$29.95

-0.45 (-1.48%)

05:17
02/23/18
02/23
05:17
02/23/18
05:17
Upgrade
Financial Engines rating change  »

Financial Engines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OKTA

Okta

$35.82

0.49 (1.39%)

05:14
02/23/18
02/23
05:14
02/23/18
05:14
Initiation
Okta initiated  »

Okta initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 26

    Feb

  • 07

    Mar

COTV

Cotiviti Holdings

$34.21

-0.32 (-0.93%)

05:11
02/23/18
02/23
05:11
02/23/18
05:11
Downgrade
Cotiviti Holdings rating change  »

Cotiviti downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARD

Ardagh Group

$19.01

0.8 (4.39%)

05:09
02/23/18
02/23
05:09
02/23/18
05:09
Recommendations
Ardagh Group analyst commentary  »

Ardagh should be bought…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$26.48

-0.29 (-1.08%)

05:03
02/23/18
02/23
05:03
02/23/18
05:03
Initiation
Boston Scientific initiated  »

Boston Scientific assumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 01

    Mar

  • 14

    Mar

SGMO

Sangamo

$25.40

3.2 (14.41%)

, GILD

Gilead

$79.40

-1.29 (-1.60%)

05:00
02/23/18
02/23
05:00
02/23/18
05:00
Recommendations
Sangamo, Gilead analyst commentary  »

Sangamo price target…

SGMO

Sangamo

$25.40

3.2 (14.41%)

GILD

Gilead

$79.40

-1.29 (-1.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EMN

Eastman Chemical

$101.51

0.42 (0.42%)

04:55
02/23/18
02/23
04:55
02/23/18
04:55
Conference/Events
Eastman Chemical management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

04:55
02/23/18
02/23
04:55
02/23/18
04:55
General news
Breaking General news story  »

Week of 2/23 Baker-Hughes…

04:55
02/23/18
02/23
04:55
02/23/18
04:55
General news
Breaking General news story  »

San Francisco Federal…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.